Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Spondyloarthritis

Which composite measures to use in psoriatic arthritis?

A new publication by the GRAPPA–OMERACT group provides recommendations and a useful framework for physicians on the use of composite measures and treatment targets in psoriatic arthritis. However, these recommendations highlight the need for more research in order to improve patient care and health-related quality of life.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Scarpa, R. et al. Psoriatic disease 10 years later. J. Rheumatol. 44, 1298–1301 (2017).

    Article  CAS  Google Scholar 

  2. Coates, L. C. et al. GRAPPA-OMERACT consensus-based recommendations and research agenda for use of composite measures and treatment targets in PsA. Arthritis Rheumatol. https://doi.org/10.1002/art.40391 (2017).

    Article  Google Scholar 

  3. Orbai, A. M. et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann. Rheum. Dis. 76, 673–680 (2016).

    Article  Google Scholar 

  4. Kirwan, J. R., Boers, M. & Tugwell, P. Updating the OMERACT filter at OMERACT 11. J. Rheumatol. 41, 975–977 (2014).

    Article  Google Scholar 

  5. Helliwell, P. S. et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann. Rheum. Dis. 72, 986–991 (2013).

    Article  Google Scholar 

  6. Mumtaz, A. et al. Development of a preliminary composite disease activity index in psoriatic arthritis. Ann. Rheum. Dis. 70, 272–277 (2011).

    Article  Google Scholar 

  7. Nell-Duxneuner, V. P. et al. Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis. Ann. Rheum. Dis. 69, 546–549 (2010).

    Article  Google Scholar 

  8. Pincus, T., Swearingen, C. J., Bergman, M. & Yazici, Y. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J. Rheumatol. 35, 2136–2147 (2008).

    Article  Google Scholar 

  9. Coates, L. C., Fransen, J. & Helliwell, P. S. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann. Rheum. Dis. 69, 48–53 (2010).

    Article  CAS  Google Scholar 

  10. Coates, L. C. et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 68, 1060–1071 (2016).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raffaele Scarpa.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scarpa, R., Caso, F. Which composite measures to use in psoriatic arthritis?. Nat Rev Rheumatol 14, 125–126 (2018). https://doi.org/10.1038/nrrheum.2018.15

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2018.15

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing